Mizuki Endo

495 total citations
26 papers, 374 citations indexed

About

Mizuki Endo is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Mizuki Endo has authored 26 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Hepatology. Recurrent topics in Mizuki Endo's work include Liver Disease Diagnosis and Treatment (7 papers), Renal cell carcinoma treatment (3 papers) and Hepatitis B Virus Studies (3 papers). Mizuki Endo is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Renal cell carcinoma treatment (3 papers) and Hepatitis B Virus Studies (3 papers). Mizuki Endo collaborates with scholars based in Japan, United States and United Kingdom. Mizuki Endo's co-authors include Masataka Seike, Hironobu Yoshimatsu, Takayuki Masaki, Mie Arakawa, Kazunari Murakami, Koichi Honda, Hirotaka Shibata, Koro Gotoh, K. Fujihara and Hidehiko Konno and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Medicine.

In The Last Decade

Mizuki Endo

21 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mizuki Endo Japan 8 180 98 88 74 65 26 374
Milena Vesković Serbia 12 162 0.9× 93 0.9× 42 0.5× 93 1.3× 63 1.0× 24 375
Babak Dehestani Ireland 6 240 1.3× 131 1.3× 31 0.4× 99 1.3× 88 1.4× 12 482
Irene Fornaciari Italy 10 132 0.7× 89 0.9× 47 0.5× 54 0.7× 18 0.3× 12 321
Sophia I. Pachydaki United States 9 60 0.3× 273 2.8× 42 0.5× 90 1.2× 50 0.8× 17 700
K. Žarković Croatia 12 69 0.4× 78 0.8× 21 0.2× 63 0.9× 43 0.7× 18 415
Maria Vulf Russia 12 117 0.7× 144 1.5× 17 0.2× 43 0.6× 91 1.4× 36 362
Annette Bellar United States 14 113 0.6× 90 0.9× 54 0.6× 14 0.2× 222 3.4× 30 384
Saravana Kumar India 10 113 0.6× 56 0.6× 18 0.2× 46 0.6× 46 0.7× 33 368
Lu Lin China 9 115 0.6× 61 0.6× 18 0.2× 147 2.0× 38 0.6× 15 297
Jingqiu Cui China 11 92 0.5× 148 1.5× 37 0.4× 107 1.4× 72 1.1× 43 491

Countries citing papers authored by Mizuki Endo

Since Specialization
Citations

This map shows the geographic impact of Mizuki Endo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mizuki Endo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mizuki Endo more than expected).

Fields of papers citing papers by Mizuki Endo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mizuki Endo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mizuki Endo. The network helps show where Mizuki Endo may publish in the future.

Co-authorship network of co-authors of Mizuki Endo

This figure shows the co-authorship network connecting the top 25 collaborators of Mizuki Endo. A scholar is included among the top collaborators of Mizuki Endo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mizuki Endo. Mizuki Endo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nakazawa, Nobuhiro, Makoto Sohda, Mizuki Endo, et al.. (2024). The Gustave Roussy Immune score is a powerful biomarker for predicting therapeutic resistance to chemotherapy in gastric cancer patients. Cancer Chemotherapy and Pharmacology. 94(4). 517–522.
3.
Endo, Mizuki, Tomoko Saito, Mie Arakawa, et al.. (2023). A case of hepatosplenic cat scratch disease with hemophagocytic lymphohistiocytosis. Clinical Journal of Gastroenterology. 16(6). 871–876.
4.
Inoue, Takako, Koji Ogawa, Mizuki Endo, et al.. (2023). Which nonhepatology departments are in urgent need of measures for treating patients positive for hepatitis virus?. Kanzo. 64(11). 587–589. 2 indexed citations
5.
Inoue, Taisuke, Tatsuya Ide, Yoshihito Uchida, et al.. (2023). Survey on measures for hepatitis B and C in liver specialty hospitals other than regional core centers. Kanzo. 64(12). 649–652. 1 indexed citations
6.
Endo, Mizuki, Koichi Honda, Tomoko Saito, et al.. (2021). Maximum Plasma Concentration of Lenvatinib Is Useful for Predicting Thrombocytopenia in Patients Treated for Hepatocellular Carcinoma. World Journal of Oncology. 12(5). 165–172. 4 indexed citations
7.
Gotoh, Koro, Yoko Kudo, Mie Arakawa, et al.. (2020). α‐Tocopherol suppresses hepatic steatosis by increasing CPT‐1 expression in a mouse model of diet‐induced nonalcoholic fatty liver disease. Obesity Science & Practice. 7(1). 91–99. 9 indexed citations
8.
Gotoh, Koro, Mie Arakawa, Mizuki Endo, et al.. (2020). Supplementation of branched-chain amino acids decreases fat accumulation in the liver through intestinal microbiota-mediated production of acetic acid. Scientific Reports. 10(1). 18768–18768. 44 indexed citations
9.
Honda, Koichi, Masataka Seike, Mizuki Endo, et al.. (2017). Usefulness of semiquantitative PCR‐Invader assay for selecting candidates for daclatasvir plus asunaprevir combination therapy among patients with hepatitis C virus genotype 1b. Hepatology Research. 48(4). 255–263. 2 indexed citations
10.
Honda, Koichi, Masataka Seike, Mizuki Endo, et al.. (2016). Risk factors for deterioration of long-term liver function after radiofrequency ablation therapy. World Journal of Hepatology. 8(13). 597–597. 3 indexed citations
11.
Arakawa, Mie, Koichi Honda, Masataka Seike, et al.. (2015). Focal nodular hyperplasia-like lesion of progressive type in a patient with congenital hepatic fibrosis: a case report. Kanzo. 56(9). 461–468.
12.
Arakawa, Motoki, Naoshige Uchida, Tsutomu Odani, et al.. (2014). Influence of losartan intake on the circadian rhythm of melatonin secretion in humans.. PubMed. 69(3). 192–7. 3 indexed citations
13.
Inoue, Megumi, Masataka Seike, Takayuki Masaki, et al.. (2012). High alanine aminotransferase level as a predictor for the incidence of macrovascular disease in type 2 diabetic patients with fatty liver disease. Hepatology International. 7(2). 555–561. 2 indexed citations
14.
Terajima, Masahiko, Mizuki Endo, Yoshimitsu Aoki, et al.. (2008). Four-dimensional analysis of stomatognathic function. American Journal of Orthodontics and Dentofacial Orthopedics. 134(2). 276–287. 20 indexed citations
15.
Endo, Mizuki, Takayuki Masaki, Masataka Seike, & Hironobu Yoshimatsu. (2007). TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c).. PubMed. 232(5). 614–21. 185 indexed citations
16.
Endo, Mizuki, Takayuki Masaki, Masataka Seike, & Hironobu Yoshimatsu. (2006). Involvement of stomach ghrelin and hypothalamic neuropeptides in tumor necrosis factor-alpha-induced hypophagia in mice. Regulatory Peptides. 140(1-2). 94–100. 16 indexed citations
17.
Nakamura, Masashi, Mizuki Endo, Kazuhiro Murakami, et al.. (2005). An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion. Multiple Sclerosis Journal. 11(6). 735–738. 25 indexed citations
18.
Masaki, Takayuki, Seiichi Chiba, Hiroshi Tatsukawa, et al.. (2005). The role of histamine H 1 receptor and H 2 receptor in LPS‐induced liver injury. The FASEB Journal. 19(10). 1245–1252. 30 indexed citations
19.
Hoshi, Senji, Makoto Satoh, Chikara Οhyama, et al.. (2003). Active chemotherapy for bone metastasis in sarcomatoid renal cell carcinoma. International Journal of Clinical Oncology. 8(2). 113–117. 8 indexed citations
20.
Sudo, Akira, Mizuki Endo, & Seiichi Saito. (2000). [Serum anti-arrestin antibody and disease activity of multiple sclerosis--a case report of 4-year-old child].. PubMed. 32(5). 415–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Milena Vesković Breakdown of academic impact, for papers by Babak Dehestani Breakdown of academic impact, for papers by Irene Fornaciari Breakdown of academic impact, for papers by Sophia I. Pachydaki Breakdown of academic impact, for papers by K. Žarković Breakdown of academic impact, for papers by Maria Vulf Breakdown of academic impact, for papers by Annette Bellar Breakdown of academic impact, for papers by Saravana Kumar Breakdown of academic impact, for papers by Lu Lin Breakdown of academic impact, for papers by Jingqiu Cui
Rankless by CCL
2026